Evidence map›Paper›PMID 20197426›Full record

ArticleThe New England journal of medicine2010

Choosing asthma step-up care.

Erika von Mutius, Jeffrey M Drazen

Abstract readEditorialComment
PubMed Publisher
In one paragraph

Article in The New England journal of medicine, 2010. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 12 papers, 2 of them syntheses that pooled it.

0numbers the graph read from it
0cells of the map it votes in
12citing papers in PubMed, 2 pooled it
–field-weighted citation impact
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

12 citing papers in PubMed, 2 syntheses or guidelines pooled it.

  1. Genome-wide association studies of exacerbations in children using long-acting beta2-agonists.Pediatric allergy and immunology : official publication of the European Society of Pediatric Allergy and Immunology · 2021
    Pooled it
  2. Pooled it
  3. Therapeutic Effects of a Long-Acting Cholinergic Receptor Blocker, Tiotropium Bromide, on Asthma.Medical science monitor : international medical journal of experimental and clinical research · 2018
    Trial
  4. Trial
  5. Trial
  6. Article
  7. Article
  8. Anticholinergics/antimuscarinic drugs in asthma.Current allergy and asthma reports · 2014
    Review
  9. The potential of biologics for the treatment of asthma.Nature reviews. Drug discovery · 2012
    Review
  10. Article
  11. Biologics in asthma--the next step toward personalized treatment.The journal of allergy and clinical immunology. In practice
    Review
  12. Severe asthma in children.The journal of allergy and clinical immunology. In practice
    Review
4 · The record

Corrections and comments

5 · Who and what money

Authors and funding

2 authors.

Erika von Mutius
Jeffrey M Drazen

Funding

No grant is acknowledged in the PubMed record.

6 · The paper itself

Abstract

PubMed holds no abstract for this paper.

Indexed as

AcetatesAdolescentAlbuterolAndrostadienesAsthmaBronchodilator AgentsChildCyclopropanesDrug Therapy, CombinationFluticasoneHumansQuinolinesSalmeterol XinafoateSulfidesAcetatesAlbuterolAndrostadienesBronchodilator AgentsCyclopropanesFluticasonemontelukastQuinolinesSalmeterol XinafoateSulfides

Identifiers

PMID20197426

What OpenQuestion holds

Textmetadata
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.